Daxor Corporation Announces Appointment of Dr. Donald Margouleff to Director of Nuclear Medicine.NEW YORK -- Daxor Corporation (AMEX AMEX See: American Stock Exchange :DXR), a medical instrumentation and biotechnology company, announces that Dr. Donald Margouleff, an expert in the field of Nuclear Medicine, has joined its staff as Daxor's Director of Nuclear Medicine. Nuclear Medicine consulting services will be offered to the medical industry under his direction. Dr. Margouleff is Board certified in both Nuclear Medicine and Internal Medicine. He holds the title of Professor of Clinical Medicine at the New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the School of Medicine and is Chief Emeritus of the Division of Nuclear Medicine of the North Shore University Hospital in Manhasset, N.Y. In 1987, before PET was generally accepted in the field of medicine, a prototype PET scanner and medical Cyclotron cyclotron: see particle accelerator. cyclotron Particle accelerator that accelerates charged atomic or subatomic particles in a constant magnetic field. were installed under his direction at North Shore University Hospital. In addition to the clinical and research applications, in collaboration with Cardinal Health, Dr. Margouleff set up a system which now delivers PET tracer to many hospitals in the New York metropolitan area New York–Northern New Jersey–Long Island is the most populous metropolitan area in the United States and the third most populous in the world, after Tokyo and Mexico City. . Dr. Margouleff was appointed chairman of the Radiological Health Advisory Committee to the Bureau of Environmental Radiation Protection of the New York State Health Department in 1982 and served in this capacity until 2005. He is a Fellow of the American College of Physicians The American College of Physicians (ACP) is a national organization of doctors of internal medicine (internists), physicians who specialize in the prevention, detection and treatment of illnesses in adults. and is a member of the American Thyroid Association. He is on the editorial board of the journal Clinical Nuclear Medicine. Dr. Margouleff's services would be available to hospitals that are considering expanding nuclear medicine services and incorporating tests such as blood volume analysis. Blood volume measurement is essential for accurate diagnosis and treatment in conditions such as congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. , anemia, and syncope syncope Effect of temporary impairment of blood circulation to a part of the body. It is often used as a synonym for fainting, which is loss of consciousness due to inadequate blood flow to the brain. (fainting). These are conditions in which blood volume derangements are common. He will also be available to organizations that manufacture and distribute nuclear medicine instrumentation or are involved in the production of new radio- pharmaceuticals and invites inquiries regarding his consulting services. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. Idant Laboratories, Daxor's subsidiary, started the first personal frozen blood storage programs and one of the first frozen semen storage centers. For more information visit Daxor's website www.Daxor.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion